Epilepsy secondary to active or inactive neurocysticercosis (NCC) is a major public health
problem in Latin American countries. In an open‐label pilot trial, we evaluated and followed�…

Epilepsy secondary to active or inactive neurocysticercosis (NCC) is a major public health
problem in Latin American countries. In an open-label pilot trial, we evaluated and followed�…

In an open-label pilot trial involving 16 patients (aged 12 to 68 years) in Mexico, with
epilepsy resulting from active neurocysticercosis (NCC), the effect of anticysticercal (ACC)�…

Epilepsy secondary to active or inactive neurocysticercosis (NCC) is a major public health
problem in Latin American countries. In an open-label pilot trial, we evaluated and followed�…

Effect of anticysticeral treatment on the prognosis of epilepsy in neurocysticercosis : a pilot
trial CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple�…

Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot
trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索�…